SEC Form 4 · accession 0001415889-16-007038
Niagen Bioscience, Inc. · NAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank L Jaksch Jr.
Officer — CEO, PRESIDENT · Director
Period of report
Sep 1, 2016
Accepted (ET)
Sep 2, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386570
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 1, 2016 | P | 1,500 | $3.32 | A | 199,557 | D | |
| Common StockF1 | holding | — | — | — | 2,075,052 | I | By Black Sheep, FLP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person no longer has a reportable beneficial interest in 476,334 shares of the Issuer's common stock owned by FMJ Family Limited Relationship and included in the Reporting Person's prior ownership reports.